New tools to illuminate the disease
By Cindy Spence

Greg Sawyer got a text as he was walking into a meeting of the University of Florida’s new cancer engineering team, a group of doctors and engineers who collaborate, often side by side, to build tumors so that new cancer therapies can be tested. The text was from a colleague, a doctor, who said he wouldn’t make the meeting. A treatment strategy for a patient had failed and he needed to break the news.

His message: “She really needs this.”

The engineers and doctors understand that urgency. They refer to cancer engineering as a “failure is not an option” project.

The phrase suits a moonshot. Its origin is the Apollo 13 mission. The aerospace engineers at NASA knew they were sending friends into danger and that bringing them home would require a very large team of scientists and engineers to do their jobs exactly right. 

In the cancer engineering lab, there is a team, too, building an infrastructure that has never existed before to coax cancer cells into forming 3D tumors that can then be bombarded with therapies. If it works — or when — it could speed up investigations of drug therapies by orders of magnitude. But first, the lab has to be finished, the trays for the cells have to be hand-machined and the painstaking process of growing tumors must be refined. What’s more, there’s not a lot of funding for infrastructure and labs that no one quite understands yet. 

“All these words you hear at conferences, that this is an exciting time, advances are being made…” says Sawyer, an engineer and a cancer patient. “This is not fun. It’s not an exciting time. We all just want this to be over.

“Failure is not an option.”


For the moonshot on Cancer Engineering — 3D Tumors for Cancer Research, the team asked for a microscope. At $500,000, it’s not just any microscope, but a high-speed confocal microscope that can yield high-resolution studies of tumors, immune cells and drugs in 3D.

The ability to study tumors in 3D is a key to cancer engineering but required a new tool. That tool emerged from the lab of engineering researcher Tommy Angelini, who had been working on a method to create 3D structures out of cells when he began using a granular microgel, which has properties of both solids and liquids. Sawyer challenged him to print something he thought was impossible — a jellyfish. In traditional 3D printing the wispy tentacles at the base would have crashed under the weight of the head, but the microgel held the jellyfish in place. Angelini’s soft matter printing method was quickly incorporated into the Cancer Engineering Lab.

Cancer cells in 3D are important to research because cancer itself is a 3D system. Studies of cells in petri dishes are 2D, so they fall short of mimicking cancer in the human body. Cells and tumors in mice are 3D, but not all cancers will grow in mice, and growing cancer in mice to test therapies is expensive and time-consuming. By the time a tumor grows in a mouse, and a therapy is tested only to fail, a patient may not have time to wait for the next mouse model.

Growing cells and tumors in microgel allows them to behave much the way they would behave in the human body, expanding naturally. And microgel is permeable, so immune cells and various drugs at various concentrations can be tested, all at the same time. Cancer is different person to person, so ideally, the lab could harvest a patient’s own cancer cells, grow them in the lab and test as many therapies as a doctor wants to test.

That’s where the microscope comes in. When the cancer cells and tumors are bombarded with drugs or immunotherapy, their reaction can be watched through the high-speed confocal microscope. The microscope can image cell and tumor sections roughly the thickness of a human hair, showing in minute detail how the tumor reacts when a therapy — immunotherapeutic T cells for example — are introduced.

CAR T-cell Therapy


Immunotherapy is the specialty of Dr. Duane Mitchell, a specialist in brain tumor therapy.

Mitchell studies glioblastoma, the most common malignant brain tumor in the adult patient population. The majority of patients who are diagnosed with a malignant brain tumor present with stage four disease, or glioblastoma. Standard treatment is aggressive and includes surgery, radiation and chemotherapy. Still, the average survival is about 15 to 18 months after diagnosis.

Mitchell says immunotherapy can safely target malignant brain tumors, and it is less toxic and better tolerated. 

“Immunotherapy is really an attempt to engage the patient’s own immune system in fighting the advancement of malignant disease,” says Mitchell, the Phyllis Kottler Friedman professor, Department of Neurosurgery, and co-program leader, Cancer Therapeutics & Host Response research program, UF Health Cancer Center. “There are a number of experimental approaches that we and others are pursuing to try to engage the immune system to fight tumors.”

The trick is to get immunotherapy to recognize the cancerous cells as abnormal and attack them but leave the healthy cells around the tumor untouched.

“Immunotherapy is really an attempt to engage the patient’s own immune system in fighting the advancement of malignant disease. There are a number of experimental approaches that we and others are pursuing to try to engage the immune system to fight tumors.” — Dr. Duane Mitchell, Co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy

Watching the interactions of activated T cells with cancer cells requires the high-speed, high-resolution imaging of the confocal microscope. With the microscope, the tumor microenvironment is enlarged and the migration of T cells toward cancer cells can be watched, then the invasion of cancer cells by T cells, and then the T cells killing cancer cells. By using time-lapse studies, the researchers hope to identify the critical steps and cellular activity at every step in this process.

In a subset of patients who received immunotherapy combined with standard therapies, such as chemotherapy and radiation, there has been some success. 

In a phase one clinical trial, a New York woman treated with an immunotherapy vaccine has had no evidence of recurrence in 16 years, Mitchell says. Others in that cohort, about 30-40 percent of those treated, are five years post-treatment with no recurrence. Phase two of that clinical trial, funded by the National Cancer Institute, is being led by UF in collaboration with Duke University. The trial has a target of treating 120 patients with glioblastoma and has enrolled over 40 patients so far.

“Getting this to work effectively in all patients is a challenge,” Mitchell says. 

The process of getting T cells to recognize, invade and attack a tumor has several signals along the pathway, and in instances where immunotherapy does not work, it turns out that cancer cells are blocking the signals and the immunity cycle is not complete. So, watching T cells at work can show where T cells are blocked.

“One of the big efforts in our work is to try to understand why some patients have remarkable, durable responses and others do not,” Mitchell says.


Discovering why some patients are responders and others are not will require 3D tumor assays that can be studied and perhaps manipulated. Using the new microscope, the lab can perform time-lapse studies, which could reveal the mechanisms of immunotherapy.

The brand-new lab emerging on the ground floor of a mechanical engineering building is a hybrid of a medical lab and an engineering lab, doctors and engineers alike in white coats in a clean environment. The new microscope is up and running.

Lab director Padraic Levings, on loan from the Department of Orthopaedics and Rehabilitation, says working with engineers has been interesting. He points to a table made of stone, a stable surface to reduce vibration. He mentioned in an offhand way to one of the engineers his need for such a table, and when he came in the next day, there it was.

“In a molecular biology lab you might glue things together for certain purposes,” Levings says. “We might think, ‘man if we could just build a tool to do this.’ For these guys, it’s like ‘how big do you want it to be, what do you want it to do, when do you want it?’”

That can-do spirit permeates the cancer engineering lab, where the team finds it unfathomable that the mortality rate for many cancers has remained largely unchanged for the past 50 years. Putting cancer through the paces engineers use to solve problems could yield new therapies, once they fine-tune the infrastructure for marrying mechanics and biology.

The engineers want people to understand what’s possible when engineering and medicine collaborate. And they’re hoping to recruit other engineers and doctors to help.

“We don’t want to be alone. We have a different lab. Nobody else has this lab, and that’s not making me happy,” Sawyer says. “I don’t want to be the only cancer engineering lab. I want one at every university.” 


  • W. Gregory Sawyer, Ebaugh Professor, Department of Mechanical and Aerospace Engineering and Member, UF Health Cancer Center
  • Duane Mitchell, Phyllis Kottler Friedman Professor, Department of Neurosurgery, and Co-Program Leader, Cancer Therapeutics & Host Response research program, UF Health Cancer Center 

This article was originally featured in the Summer 2019 issue of Explore Magazine.

机机桶机机免费观看 把女的下面扒开添免费视频 另类专区中文 蜜柚视频app 麻豆传媒在线视频播放 亚洲最大的黄色网站 骚虎在线 swag圣诞节 色视频线观看在线播放 食色app污短视频网站 向日葵视频app下载污 免费可以看污app 泽艺在线 swag在线观看完整视频 春水堂软件苹果版 婷庭五情天 免费 猫咪社区 芊芊影视 任我橹这里有精品视频在线 prohub官网入口 男生肌肌桶女人免费版 橘梨纱紧缚において中出 全部AV免费手机在线观看 俄罗斯肥婆胖妞牲交 萝福利莉56 德田完整视频在线观看 2020AV天堂网 被黑人玩翻白眼的亚裔女 秋葵app下载在线版 鲁啊鲁啊在线观看免费 4480yy午夜私人影院 丝瓜视频I视频污app下载 百炼成神漫画免费 汤姆高清在线观看 chengrendongman 史上最狂深喉呕吐调教 免费爱做网站在线看 人妻无码手机在线视频 男女视频网站 182tvcom线路二 在线视频 国产 亚洲 素人 欧美videossexohd潮喷 恋夜秀场全部排列表安卓请 女王视频免费专区 思思99re66热这里只有精品 丝瓜视频在线观看草莓视频在线观看 www.xy16app 7m分类 精品大全免费 13一18sex破除 小恶魔app下载官方网 草莓视频app最污网站 5G确认年龄进入 年轻人看的视频大全 菠萝蜜app 柠檬网 在线电影 美女销魂试看片 爱情岛论坛免费观看线路1,2, 艳女伦交 pp1.app在哪下载 日本被下媚药的av系列 触手肉动漫无修在线播放 火暴社区 欢喜视频在线观看直播 美罗城厕所高清60部 我吃哺乳老师的奶水电影 ×关晓彤小说 91香蕉app官网下载ios 豆奶短视频破解版 2020 茄子视频下载污污app 小v视频进 我要看a片 最残忍Gay男性奴调教视频 重考生漫画免费阅读完整 口工泰罗奥特曼超退化 兄妹蕉谈完整版在线 麻豆 半岛影视 日韩av在线播放 向日葵app下载污下载ios 免费完整GV片在线播放 依恋视频 我要看a片 幻想影院 婬色男女乱婬视频 久久在精品线影院 干少妇 欧美性爱视频 桃色视频大全 芭乐视频在线观看免费视频 欢喜视频在线观看直播 秘密教学第40集 无码国产精品高清免费 拍拍拍1000无档免费视频 上色的视频美国 最不干净的女明星是谁 午夜福利电影 1级杨玉环 重播黑帽门观看 西瓜视频无线免费大全下载 食色app成版人下载短视频 免费国内大量揄拍在线视频 阴道图片 女人性高朝床叫视频尖叫 很污的app免费版 免费120秒 劳拉失忆症第02集 yy8098影视理论三级在线看 一本到高清视频播放不卡 火影忍者纲手Av在线观看 黄色激情小说 黑人极限深喉到胃 亚洲小说 蜜桔视频大全 火暴社区 久久网 色综合视频一区二区 在线播放中文HTMSFAX 丝瓜视频网站污app下载 裸条门全集在线观看 tentacion高清照片 欧美性爱视频 swag视频在线观看 扒开双腿猛进入午夜 奶茶视频下载 番茄社区app直播官网下载入口 依恋app 秘密教学46 swag 在线观看 爱情论坛观看路线一免费 讯雷哥在线观看电视剧 妖精视频app在线观看 欢喜视频在线观看直播 欧美性爱 午夜影院免费试看 泡芙约会 猛虎视频app下载免费草莓 依恋app 俄罗斯old青年old老太 .www红色一片在线 美罗城厕所高清60部 立川理惠 小苹果污软件免费 亚洲国产在线午夜视频无 五月天婷婷在在线视频 秘密教学在线漫画全集 国产粉嫩小视频在线观看 大秀直播平台聚合 兄妹蕉谈完整版在线 麻豆 在线观看不卡 泡芙app破解版免登录 swag没有免费视频吗 青青青国产手线观看视频2019 扶老二官方 菠萝蜜视频菠萝蜜网站污 樱花视频免费视频 泡泡影视 暖暖视频日本在线观看 光棍影院2020 李宗瑞全集 柚子直播软件下载 app 婬色男女乱婬视频 2japanvoise教师 女生污污的视频,免费高清 杏吧1314直播app官方下载 忍着娇喘在公面前被夜袭 含蓄草 国产午夜精品视频在线播放 校园契约3D免费漫画71话 蚂蚁种子 忍着娇喘在公面前被夜袭 爱情论坛观看路线一免费 九九线精品视频在线观看视频 名优馆app官网下载新版 18成熟女性外生殖真人 翔田千里免费中文字幕 泷泽萝拉第二部在观线看1 顶级片 狗狗进去就变大视频 暖暖视频免费播放 苦瓜视频 第一精品福利导福航 女王视频免费专区 富二代app官网下载免费版 搞逼视频 [台湾swag]在线观看 mm131杨晨晨紧身 半岛影视 暖暖视频免费观看在线 菠萝蜜在线视频 榴莲视频app下载安装 汤姆高清在线观看 老子电影院 午夜福利1000集92合集在线看午夜福利 豌豆直播看大秀 第一精品福利导福航 裸条门全集在线观看 秋葵视频APP安装下载大全 色综合欧美在线视频区 国产粉嫩小视频在线观看 李宗瑞视频 潢色网站 2012中文字幕视频 爆乳美女午夜福利视频 杏趣直播BD电影 麻豆传媒最新观看地址 食色app污短视频网站 激情深爱网 花与蛇 m3 秋葵app下载在线版 快狐官网下载最新 秋葵官方网站下载app 五月桃花网 小草高清视频在线观看 秘密教学在线漫画全集 小草 视频 在线 观看 pr18九天狐图片 狱火重生在线观看免费 水果视频免费版下载安装 七妹免费视频 杏趣直播BD电影 蜜桃成熟时1993年版在线观看 国产学生无码视频 青青河边草免费观看2019 水果视频.app 污免费下 秋葵ios下载安装 久爱成疾在线视频播放 仙桃影视 百闻影视 pr18九天狐图片 如何下载swag app 年轻人片在线观看免费 好翁息肉欲TXT下载